GCG and metabolic syndrome: A small placebo controlled human clinical trial on fifteen individuals per treatment group found that 45 days of butyrate supplementation increased GLP-1 secretion but did not significantly alter plasma cholesterol [32], and yet another small study, and without a placebo arm, found that butyrate increased LDL-C levels in subjects with the metabolic syndrome [33].